167 related articles for article (PubMed ID: 3542445)
1. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.
Uttenthal LO; Ukponmwan OO; Ghiglione M; Bloom SR
Dig Dis Sci; 1987 Feb; 32(2):139-44. PubMed ID: 3542445
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas.
Uttenthal LO; Ukponmwan OO; Wood SM; Ghiglione M; Ghatei MA; Trayner IM; Bloom SR
Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158
[TBL] [Abstract][Full Text] [Related]
3. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M
Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436
[TBL] [Abstract][Full Text] [Related]
4. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
O'Dea K; Turton J
Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
[TBL] [Abstract][Full Text] [Related]
6. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
[TBL] [Abstract][Full Text] [Related]
7. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
[TBL] [Abstract][Full Text] [Related]
8. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo.
Madariaga H; Lee PC; Heitlinger LA; Lebenthal E
Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Krause HP; Keup U; Puls W
Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
[TBL] [Abstract][Full Text] [Related]
10. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
Santeusanio F; Compagnucci P
Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
[TBL] [Abstract][Full Text] [Related]
11. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
[TBL] [Abstract][Full Text] [Related]
13. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR
Digestion; 1985; 32(2):124-7. PubMed ID: 3899816
[TBL] [Abstract][Full Text] [Related]
14. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
[TBL] [Abstract][Full Text] [Related]
16. Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor.
Füessl HS; Adrian TE; Uttenthal LO; Bloom SR
Klin Wochenschr; 1988 Oct; 66(19):985-9. PubMed ID: 3054280
[TBL] [Abstract][Full Text] [Related]
17. Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man.
Dimitriadis G; Tessari P; Go V; Gerich J
Metabolism; 1982 Aug; 31(8):841-3. PubMed ID: 7047984
[TBL] [Abstract][Full Text] [Related]
18. alpha-Glucosidase inhibition in obesity.
William-Olsson T
Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
[TBL] [Abstract][Full Text] [Related]
19. Combined use of guar and acarbose in reduction of postprandial glycaemia.
Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
[TBL] [Abstract][Full Text] [Related]
20. Effect of motilin on the rate of gastric emptying and gut hormone release during breakfast.
Christofides ND; Modlin IM; Fitzpatrick ML; Bloom SR
Gastroenterology; 1979 May; 76(5 Pt 1):903-7. PubMed ID: 374176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
